Work

Abstract PS1-11-04: Her2-low expression is associated with inferior progression-free survival in hr-positive metastatic breast cancer treated with CDK4/6 inhibitors

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-11-04

Authors: F. Kemik, B. Koylu, C. I. Kikili, N. Demir, B. Guney, A. K. Guren, E. Karanci, D. Tunali, S. Lacin, D. Tural, R. U. Gursu, O. Kostek, D. Kivrak Salim, F. Selcukbiricik, S. Gunduz

Institutions: Koç University, İstanbul Eğitim ve Araştırma Hastanesi, Marmara University, Antalya Eğitim ve Araştırma Hastanesi

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129315073

Cites:

Cited by:

Related to: